A Novel Scoring System for Patients with Recurrence of Hepatocellular Carcinoma After Undergoing Minimal Invasive Therapies

BACKGROUND: The higher recurrence rate of hepatocellular carcinoma (HCC) needs to be urgently controlled. However, definitive markers are lacking for patients with recurrence of HCC after undergoing minimal invasive therapies—local ablation combined with transcatheter arterial chemoembolization (TAC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Manag Res
Main Authors: Wang, Qi, Ma, Liang, Li, Jianjun, Yuan, Chunwang, Sun, Jianping, Li, Kang, Qin, Ling, Zang, Chaoran, Zhao, Yanan, Zhao, Yan, Zhang, Yonghong
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6930388/
https://ncbi.nlm.nih.gov/pubmed/31908536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S224711
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados